Chapter 13 - Parkinson's Disease Flashcards
Epidemiology of Parkinson’s
- most common among elderly, avg age of onset is 55 y.o.
- higher prevalence in men
Morphological patterns of Parkinson’s
- affected areas include:
- substantia nigra (loses pigment due to neuronal loss)
- locus coeruleus
- basal ganglia, cortex brainstem, spinal cord
Main/Direct Pathway
decrease D1 receptors
Indirect Pathway
increase D2 receptors
Biochemical patterns of Parkinson’s
- mainly affects DA
- Norepi and 5-HTA also affected
- Lewy bodies present - NOT the same as Lewy dementia
What correlate to the pigment loss in the substantia nigra and locus coeruleus?
Lewy bodies and Lewy neurites
Motor features of Parkinson’s
- resting tremor (usually starts small, like with a finger)
- rigidity (shuffle when walking, facial masking, blink less)
- bradykinesia (diff. initiating motor plans and w/ fine motor movement)
- postural instability (tested w/ Riding reflex)
- gait disturbance
Other clinical features of Parkinson’s (sensorimotor and mood)
- depression (could be due to low levels of norepinephrine and serotonin)
- dementia (towards late stage, NOT a dementia)
- Hallucinations and psychotic behavior (due to increased activity in indirect pathway)
- REM-related sleep disorders
- olfactory disturbance (early sign, occurs before motor symptoms)
Etiology of Parkinson’s
- exact cause unknown, but there are theories:
- oxidative damage (increase of free radicals causes cell death)
- environmental toxins (chronic exposure to insecticides and pesticides)
- genetic predisposition (very rare, involves gene encoding for alpha synuculein)
Diagnosis of Parkinson’s
- Bradykinesia must be present w/ at least two of the following: limb muscle rigidity, resting tremor, or postural instability
- must eliminate secondary causes like: drug related, stroke, AZ, or Lewy body disease
Time course of Parkinson’s
- mild stage lasts approx 5 years, pt experiences balance and gait impairment, begins to consider medication
- after 5 years, pt has motor fluctuations, dyskinesias, and behavioral or cognitive changes
Clinicopathologic correlations in Parkinson’s
- neuronal loss in the substantia nigra must exceed 50% before motor symptoms appear
- 80-90% neurons are lost by the end of disease
Treatment of Parkinson’s (motor symptoms)
- Levodopa (L-dopa)
- precursor for dopamine
- w/n 5 years, pt becomes less sensitive/responsive to the medication, and motor symptoms return
Treatment of Parkinson’s (psychiatric symptoms)
- antipsychotics can be used to treat hallucinations, but can worsen motor symptoms
- however, Seroquel can reduce psychosis
What three regions are targeted for surgical intervention (lesioning)?
- thalamus
- globus pallidus
- subthalamic nucleus
What is typically the best surgical intervention for Parkinson’s?
- deep brain stimulation to areas that will stop tremors